Home » Stocks » Heron Therapeutics » Financials » Income Statement

Heron Therapeutics, Inc. (HRTX)

Stock Price: $15.53 USD -0.51 (-3.18%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Heron Therapeutics Income Statement (Annual)

The table below shows the annual income statements for Heron Therapeutics stock for the past 25 years.

Numbers in millions USD. Fiscal year is January-December.
Year2019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995
Revenue14677.4730.771.28----0.651.301.260.370.41-5.395.404.854.673.273.374.703.0717.2117.6616.11
Revenue Growth88.41%151.81%2305.55%------50.35%3.17%241.73%-10.44%---0.24%11.47%3.81%43.03%-3%-28.33%52.77%-82.13%-2.57%9.64%-
Cost of Revenue61.6227.514.590.04---------------0.500.530.327.1610.7711.05
Gross Profit84.3549.9626.181.24----0.651.301.260.370.41-5.395.404.854.673.272.874.162.7510.046.895.06
Selling, General & Admin12893.8782.1669.0335.7419.7321.948.663.503.973.714.314.683.633.573.233.043.313.253.463.442.557.3611.449.64
Research & Development16714013910361.1854.8332.5215.178.217.267.8019.5119.3615.2410.3011.508.426.417.353.712.472.373.743.514.14
Operating Expenses29523422117296.8175.4854.4623.8311.7111.2411.5023.8124.0518.8613.8614.7211.319.6610.517.155.924.9411.1716.3214.29
Operating Income-211-184-195-171-96.81-75.48-54.46-23.83-11.06-9.93-10.24-23.45-23.63-18.86-8.47-9.32-6.46-4.99-7.24-4.28-1.75-2.19-1.13-9.43-9.23
Income Taxes-----------0.12-0.040.12-----------
Interest Income/Expense-5.79-3.292.892.220.780.890.830.610.37-0.24-0.02-0.59-1.33-1.01-0.29-0.20-0.25-0.59-1.11-0.520.380.560.681.550.13
Other Expense/Income-5.95-5.102.932.230.780.890.83-0.480.75-2.59-0.09-0.32-3.51-24.25-0.26-0.10-2.10-1.21-4.73-12.83-4.13-4.710.68-0.050.13
Net Income-205-179-197-173-97.59-76.37-55.28-23.35-11.81-7.35-10.03-23.13-20.165.27-8.21-9.22-4.36-3.78-2.518.552.372.53-1.81-9.38-9.36
Shares Outstanding81.7873.1954.0437.9333.0826.5716.1612.226.011.981.631.540.970.320.310.290.260.260.250.250.250.250.230.220.21
Shares Change11.73%35.44%42.49%14.64%24.51%64.38%32.23%103.28%203.07%21.64%5.87%59.16%206.49%0.57%9.65%11.46%0.71%0.66%0.48%0.5%1.13%5.73%4.4%9.28%-
EPS (Basic)-2.50-2.44-3.65-4.56-2.95-2.87-3.42-1.91-1.96-3.70-6.15-15.00-20.8016.60-26.20-32.00-16.80-15.20-9.6033.609.6010.40-8.00-46.40-45.60
Earnings Per Share (EPS)-2.50-2.44-3.65-4.56-2.95-2.87-3.42-1.91-1.96-3.70-6.15-15.00-20.8016.60-26.20-32.00-16.80-15.20-9.6033.609.609.60-8.00-46.40-45.60
EPS Growth-------------------250%0%----
FCF Per Share-1.61-2.75-3.20-3.62-2.40-2.32-2.63-1.47-1.37-2.80-6.75-15.95-18.3528.48-24.98-26.61-25.62-21.80-26.70-13.06-4.06-17.39-2.77-30.41-41.91
Gross Margin57.8%64.5%85.1%97.3%----100%100%100%100%100%-100%100%100%100%100%85.2%88.7%89.6%58.4%39%31.4%
Operating Margin-144.3%-237.4%-632.4%-13,363.2%-----1,712.4%-763.6%-812.2%-6,353.7%-5,736.2%--157.2%-172.4%-133.2%-106.7%-221.8%-127.2%-37.3%-71.1%-6.5%-53.4%-57.3%
Profit Margin-140.3%-230.8%-641.9%-13537.4%-----1828.8%-564.6%-795.2%-6266.9%-4893.9%--152.3%-170.6%-90%-80.9%-77%254.1%50.5%82.1%-10.5%-53.1%-58.1%
FCF Margin-90.2%-259.4%-561.6%-10,729.6%-----1,274.6%-427.4%-872.4%-6,659.3%-4,311.2%--145.5%-141.0%-135.8%-119.1%-207.3%-97.9%-21.7%-140.4%-3.8%-38.7%-53.5%
EBITDA-208-181-193-170-96.07-74.90-54.12-22.55-11.26-7.36-9.82-23.30-21.094.77-8.11-9.04-4.18-3.92-3.238.403.143.46-0.15-6.44-7.85
EBITDA Margin-142.8%-233.1%-627.5%-13278%-----1743.3%-565.5%-778.6%-6314.4%-5118.7%--150.4%-167.3%-86.3%-83.9%-98.9%249.7%66.8%112.6%-0.8%-36.5%-48.8%
EBIT-211-182-195-171-96.81-75.48-54.46-22.74-11.44-7.58-10.17-23.71-21.454.38-8.50-9.42-4.61-4.37-3.628.032.763.08-1.13-7.83-9.23
EBIT Margin-144.2%-235.1%-632.5%-13,363.9%-----1,771.1%-582.9%-806.8%-6,426.0%-5,205.8%--157.6%-174.4%-95.2%-93.5%-110.8%238.5%58.7%100.3%-6.5%-44.3%-57.3%